PDPL.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (21 8月 2023 @ 17:15):

Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc...

Stats
本日の出来高	1 063.00
平均出来高	0.00
時価総額	101.08M
EPS	INR7.99 ( 2022-03-31 )
Last Dividend	INR1.125 ( 2010-09-13 )
Next Dividend	INR0 ( N/A )
P/E	-0.110
ATR14	INR0.0200 (0.69%)

ボリューム相関

長: -0.05 (neutral)

短: 0.00 (neutral)

Signal:(33.266) Neutral

Parenteral Drugs (India) 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Parenteral Drugs (India) 相関 - 通貨/商品

-0.26
( neutral )

0.46
( neutral )

0.00
( neutral )

0.16
( neutral )

0.71
( moderate )

-0.87
( strong negative )

Parenteral Drugs (India) 財務諸表

Annual	2022
収益:	INR84.96M
総利益:	INR30.31M (35.67 %)
EPS:	INR-25.61

FY	2022
収益:	INR84.96M
総利益:	INR30.31M (35.67 %)
EPS:	INR-25.61

FY	2021
収益:	INR121.53M
総利益:	INR48.37M (39.80 %)
EPS:	INR-40.82

FY	2020
収益:	INR240.25M
総利益:	INR13.40M (5.58 %)
EPS:	INR-38.26

Financial Reports:

No articles found.

Parenteral Drugs (India) Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Parenteral Drugs (India) Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0.0762 - No dividend growth expected in the near future

Information

First Dividend	INR1.125	2010-09-13
Last Dividend	INR1.125	2010-09-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR1.125	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0.0762
Div. Directional Score	0	--

Next Divdend (Est)
(2024-05-09)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TITAN.NS	Dividend Junior	2023-07-13	Annually	20	0.35%
PETRONET.NS	Dividend Knight	2023-08-18	Semi-Annually	18	2.36%
JASH.NS	Dividend Junior	2023-09-22	Annually	7	0.57%
DBOL.NS	Dividend Junior	2023-06-23	Insufficient data to determine frequency	2	0.56%
SILINV.NS	Dividend Junior	2023-08-18	Annually	23	0.63%
MBAPL.NS	Dividend Junior	2023-09-18	Annually	8	0.44%
GUJAPOLLO.NS	Ex Dividend Junior	2023-09-22	Annually	18	0.48%
BAYERCROP.NS	Dividend Junior	2023-08-03	Annually	15	1.25%
PREMIERPOL.NS	Dividend Junior	2023-09-11	Sporadic	9	0.39%
KAMDHENU.NS	Dividend Junior	2023-08-14	Sporadic	17	0.32%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-8.99	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.158	1.200	-5.26	-6.31	[0 - 0.3]
returnOnEquityTTM	0.101	1.500	9.99	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.0559	0.800	-4.72	-3.78	[1 - 3]
quickRatioTTM	0.00970	0.800	-4.65	-3.72	[0.8 - 2.5]
cashRatioTTM	0.0000001	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0.221	-1.500	6.31	-9.47	[0 - 0.6]
interestCoverageTTM	-0.000519	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.108	[0 - 30]
freeCashFlowPerShareTTM	-0.162	2.00	-0.0809	-0.162	[0 - 20]
debtEquityRatioTTM	-0.130	-1.500	-0.520	0.781	[0 - 2.5]
grossProfitMarginTTM	0.357	1.000	7.39	7.39	[0.2 - 0.8]
operatingProfitMarginTTM	-0.00649	1.000	-2.13	-2.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.00450	1.000	-1.136	-1.136	[0.2 - 2]
assetTurnoverTTM	0.0175	0.800	-3.22	-2.57	[0.5 - 2]
Total Score				-1.062

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.113	1.000	-0.112	0	[1 - 100]
returnOnEquityTTM	0.101	2.50	9.99	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.162	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.108	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00111	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0568	1.000	-3.92	0	[0.1 - 0.5]
Total Score				0.0762

Parenteral Drugs (India)

Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.